Similarly, another example of therapeutically targeting cell cycle essential genes in the context of specific functional vulnerabilities of cancer cells identified a specific dependency on CCNE1 (cyclin E) upregulation/amplification in tumor cells, which can be selectively targeted using inhibitors of PKMYT1 (a. The gene discussed is CCNE1; the disease is cancer.